AtriCure, Inc. (ATRC) Misses Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $43.88 +0.73%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.31), $0.09 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.36 million.
AtriCure, Inc. sees FY2014 revenue of $101-104 million, versus prior guidance of $100-103 million and the consensus of $101.91 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SuperCom (SPCB) Tops Q3 EPS by 43c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
